Unusual electrocardiographic changes with propranolol and diltiazem overdosage: a case report
Salim Satar1, Ayca Acikalin, Onur Akpinar
1Emergency Department, Faculty of Medicine, Cukurova University, Adana, Turkey. ssatar@mail.cu.edu.tr
Insights
Beta-blockers and calcium channel blockers treat cardiovascular conditions. This case study details a rare suicidal overdose of propranolol and diltiazem, highlighting unusual ECG changes and the need for careful patient monitoring.
Area of Science:
- Cardiology
- Clinical Pharmacology
- Toxicology
Background:
- Beta-adrenoreceptor-blocking drugs (beta-blockers) and calcium antagonists (calcium channel blockers) are widely used for cardiovascular conditions like angina, arrhythmias, and hypertension.
- Combination therapy with drugs like propranolol and diltiazem requires careful patient selection and monitoring due to potential adverse cardiovascular effects.
Observation:
- This article presents a unique case of a suicidal drug overdose involving both propranolol and diltiazem.
- The overdose resulted in distinct and unusual electrocardiographic (ECG) changes.
Findings:
- The case highlights the complex cardiovascular effects that can arise from an overdose of combined beta-blocker and calcium channel blocker medications.
- Specific, atypical ECG findings were observed, underscoring the potential for severe toxicity.
Implications:
- This case emphasizes the critical importance of meticulous patient selection and close observation when prescribing combination cardiovascular therapies.
- Understanding the specific toxicological profiles and ECG manifestations of combined drug overdoses is crucial for emergency medical management.
- Further research into the electrophysiological consequences of combined beta-blocker and calcium channel blocker toxicity may be warranted.
Abstract:
The therapeutic efficacy and safety of beta-adrenoreceptor-blocking drugs has been well established in patients with angina pectoris, cardiac arrhythmias, and hypertension and reducing the risk of mortality and nonfatal reinfarction on survival of acute myocardial infarction. The calcium antagonists are used for the treatment of patients with angina pectoris, long-term systemic hypertension, and the management of hypertensive emergencies and also for a multitude of other cardiovascular and noncardiovascular conditions. Because adverse cardiovascular effects can occur, however, patients being considered for combination treatment with propranolol and diltiazem must be selected carefully and observed closely. In this article, we present a suicidal case of drug overdose with propranolol and diltiazem with unusual electrocardiographic changes.
Related Concept Videos
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...

